• Illumina at JP Morgan: Tighter Focus, Consumable Growth, Short Read Market

    Bio-IT World | CEO Jacob Thaysen presented Illumina’s updates yesterday at the JP Morgan Healthcare Conference. 2023 has been an eventful year for the sequencing pioneer with December’s announcement that Illumina would divest GRAIL; Francis deSouza, Illumina’s former CEO, stepping down in June; and $175M in cost cuts over the course of 2023 which included headcount reductions and major real estate changes. Thaysen presented Illumina at a turning point.

    Jan 10, 2024

  • The LOWE Down on Recursion’s New LLM Orchestration Work Engine from JP Morgan

    Bio-IT World | Chris Gibson, CEO of Recursion, launched a live demo of Recursion’s new large language model orchestration work engine, LOWE, yesterday at the JP Morgan Healthcare Conference. The tool is the next step toward Recursion’s goal of autonomous drug discovery.

    Jan 9, 2024

  • NVIDIA at JP Morgan: Generative AI and the Computer Aided Drug Design Tipping Point

    Bio-IT World | Drug design is at a tipping point, Kimberly Powell, vice president of Healthcare for NVIDIA, argued in her Monday morning presentation at the JP Morgan Healthcare Conference. “Two necessary conditions have arrived for drugs: digitizing biology and being able to represent it in a computer. We have the perfect conditions to see a massive expansion of this computer-aided drug discovery industry,” she said. And generative AI is the class of tools that will facilitate it.

    Jan 8, 2024

  • Power of Supercomputing and AI: Revolutionizing Allosteric Drug Discovery

    Bio-IT World | Driven by advancements in technology and data accessibility, computational methods and artificial intelligence (AI) have seen remarkable growth this past decade. This surge has ushered in a new era of problem-solving across a plethora of industries and domains.

    Jan 5, 2024

  • Top Stories from 2023: Spatial Biology, Innovative Practices, Generative AI, More

    Bio-IT World | Spatial biology, large language models, and new informatics tools. Bio-IT is exploring how AI fits into workstreams, still wrangling with data management challenges, and shaping discovery for the new era. Here are the top stories from Bio-IT World as well as thought leaders in the industry.

    Jan 4, 2024

  • Trendspotting: What’s Coming for Biotech in 2024

    Bio-IT World | To kick off the New Year, we spoke with leaders and experts in the Bio-IT community about their predictions for 2024.

    Jan 3, 2024

  • Genomenon Launches Classification Service, Medidata’s New Research Alliance, New Devices, Platforms, More

    Bio-IT World | Genomenon launched Genomenon Curate-Pro variant classification service; Medidata launches the Medidata Research Alliance; Edinburgh Innovations has announced a novel 3D printed device that could replace the need for drug and chemical safety testing on animals; and more.

    Dec 28, 2023

  • Follow the Money: AI For Drug Discovery, Small Molecule Therapeutics, Multi-Omics Platform for Women’s Reproductive Immunotherapies, More

    Bio-IT World | Sanofi enters a multi-year research collaboration with French pharmatech company Aqemia; Apple Tree Partners will expand its portfolio company Deep Apple Therapeutics to rapidly discover novel small molecule therapeutics for high-value targets through virtual screening of AI-generated virtual libraries; Freya Biosciences intends to advance their multi-omics data science platform; and more.

    Dec 27, 2023

  • ‘Reverse Metabolomics’ Enables Biological Discoveries From Repository Data

    Bio-IT World | In a turnaround of the usual metabolomics study approach, University of California San Diego scientists are homing in on the microbial-produced molecules that interact with cells and affect human health. A couple million such molecules are likely awaiting discovery in this fashion.

    Dec 21, 2023

  • NIH Program Tackles Bottlenecks In ‘Wild West’ Field Of exRNA Biology

    Bio-IT World | Driven by advancements in technology and data accessibility, computational methods and artificial intelligence (AI) have seen remarkable growth this past decade. This surge has ushered in a new era of problem-solving across a plethora of industries and domains.

    Dec 20, 2023

  • Living Biobank Of Brain Metastasis Samples Enabling ‘Personalized Medicine 2.0’

    Bio-IT World | Driven by advancements in technology and data accessibility, computational methods and artificial intelligence (AI) have seen remarkable growth this past decade. This surge has ushered in a new era of problem-solving across a plethora of industries and domains.

    Dec 19, 2023

  • Illumina to Divest GRAIL Business by Q2 2024

    Bio-IT World | On Sunday, Illumina announced that the company will divest GRAIL.

    Dec 17, 2023

  • Making Data Storage More Secure, More Flexible and Less Expensive for Medical and Scientific Applications

    Bio-IT World | One of the major side effects of the massive increase in the use of artificial intelligence (AI) for basic research, translational research, clinical research, pharmaceutical development, and patient care is the tsunami of data that will be created.

    Dec 15, 2023

  • Worm-Derived Drugs May One Day Treat Allergic and Autoimmune Diseases

    Bio-IT World | The development of antibiotics for treating tuberculosis in the 1940s eventually closed the doors of high-altitude sanitoriums that had long been the best therapeutic option for millions of patients. In much the same way, researchers at the Buck Institute for Research on Aging hope to one day eliminate the need to admit people suffering from Alzheimer’s, Parkinson’s disease, and other age-related phenomena to a geriatric or psychiatric hospital.

    Dec 13, 2023

  • New Compound Added to Short List of Molecules Targeting Aging Process

    Bio-IT World | The development of antibiotics for treating tuberculosis in the 1940s eventually closed the doors of high-altitude sanitoriums that had long been the best therapeutic option for millions of patients. In much the same way, researchers at the Buck Institute for Research on Aging hope to one day eliminate the need to admit people suffering from Alzheimer’s, Parkinson’s disease, and other age-related phenomena to a geriatric or psychiatric hospital.

    Dec 12, 2023

  • For Rare Disease, What’s Missed by Genome Sequencing Still Matters

    Bio-IT World | For almost two decades, members of the life science community bemoaned something that most outsiders never realized: that the “finished” human genome assembly had never actually been finished. Now, thanks to remarkable efforts from the Telomere-to-Telomere (T2T) consortium, we finally have a complete human reference genome.

    Dec 8, 2023

  • The Last Mile In Preventing A Deadly Hospital Infection

    Bio-IT World | The “power of the team approach” was on full display for a study designed to understand the contribution of asymptomatic carriers to the spread of Clostridioides difficile in hospitals.

    Dec 6, 2023

  • Bringing Your Research to the Market With Tom Miller

    Bio-IT World | When Tom Miller was a professor at the California Institute of Technology, he built a research program centered around developing AI and data-driven algorithms to help solve chemistry and biological challenges with various research focuses. These scientific innovations led to increasingly translational capabilities, and Miller realized he had to bring his research to a bigger platform.

    Dec 5, 2023

  • Copyright Clearance Center Wins 2023 European Best of Show Award for Scientific Article Exploration Tool

    Bio-IT World | The Bio-IT World community has chosen the 2023 Best of Show Awards Europe winner. The more than 300 event attendees in London were invited to vote for their favorite solutions, and they chose to honor RightFind XML from Copyright Clearance Center (CCC) as the 2023 honoree.

    Nov 30, 2023

  • Follow the Money: AI-Designed De Novo Therapeutics, Spatial Technology, DNA Platform for Rheumatoid Arthritis, More

    Bio-IT World | Absci and Almirall announced a drug discovery partnership aimed to develop and commercialize AI-designed therapeutics to fight chronic and debilitating dermatological diseases; Stellaromics is developing next-generation spatial technology that promises to accelerate the development of fundamentally novel drug treatments, including for autoimmune diseases, cancer, and more; Aqtual intends to expand its platform that evaluates protein regulation, epigenetics, and transcriptomics; more.

    Nov 30, 2023